The osteoporosis prevention and arterial effects of tibolone (OPAL) study: design and baseline characteristics.

Translated title of the contribution: The osteoporosis prevention and arterial effects of tibolone (OPAL) study: design and baseline characteristics.

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	The osteoporosis prevention and arterial effects of tibolone (OPAL) study: design and baseline characteristics.
Original language	Undefined/Unknown
Pages (from-to)	752-775
Number of pages	24
Journal	Controlled Clinical Trials
Volume	24
Publication status	Published - 2003

Cite this

@article{8104dc275d46481e8259df09b3bdf4fa,

title = "The osteoporosis prevention and arterial effects of tibolone (OPAL) study: design and baseline characteristics.",

author = "M.L. Bots and G.W. Evans and W. Riley and R. Meyer and K.H. McBride and E.D. Paskett and F.A. Helmond and D.E. Grobbee",

year = "2003",

language = "Undefined/Unknown",

volume = "24",

pages = "752--775",

journal = "Controlled Clinical Trials",

issn = "0197-2456",

publisher = "Elsevier",

}

TY - JOUR

T1 - The osteoporosis prevention and arterial effects of tibolone (OPAL) study: design and baseline characteristics.

AU - Bots, M.L.

AU - Evans, G.W.

AU - Riley, W.

AU - Meyer, R.

AU - McBride, K.H.

AU - Paskett, E.D.

AU - Helmond, F.A.

AU - Grobbee, D.E.

PY - 2003

Y1 - 2003

M3 - Article

SN - 0197-2456

VL - 24

SP - 752

EP - 775

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

ER -